PACT Pharma

PACT Pharma is a rapidly expanding biotechnology company headquartered in South San Francisco, California. With 43 employees, the company is focused on developing innovative cancer treatments. PACT Pharma has generated $360.5 million in revenue. PACT Pharma specializes in creating personalized T cell therapies for solid tumors. Their approach uses non-viral, precision-genome engineered, tumor-specific T-cells to target and destroy cancer cells. The company aims to provide accessible and effective treatment options for patients with solid tumors worldwide. PACT Pharma prides itself on its collaborative and innovative work environment. They encourage open communication, idea sharing, and a commitment to teamwork. The company emphasizes a culture of kindness and respect, fostering a supportive and inclusive atmosphere for its employees. For more information about PACT Pharma and their groundbreaking work in cancer treatment, visit their website at pactpharma.com.